Gabelli & Co Investment Advisers’s Treace Medical Concepts TMCI Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$252K	–	272
2023 Q1	$252K	Hold	10,000	–	–	0.05%	135
2022 Q4	$230K	Hold	10,000	–	–	0.05%	177
2022 Q3	$221K	Hold	10,000	–	–	0.03%	306
2022 Q2	$143K	Hold	10,000	–	–	0.02%	345
2022 Q1	$189K	Buy	+10,000	New	+$194K	0.02%	359

Other funds holding TMCI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Gabelli & Co Investment Advisers's TMCI Position: Q2 2023 in Review

Gabelli & Co Investment Advisers sold out of Treace Medical Concepts (TMCI) in Q2 2023, closing a stake of 10,000 shares — an estimated $252K sold.

Gabelli & Co Investment Advisers first reported a position in TMCI in Q1 2022 and held it in 5 quarters. The position peaked at $252K in Q1 2023. 137 funds tracked by Wall St. Rank hold TMCI as of Q2 2023.

Gabelli & Co Investment Advisers reported no remaining Treace Medical Concepts position as of Q2 2023 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 10,000 Treace Medical Concepts shares in Q2 2023, an estimated $252K.
Gabelli & Co Investment Advisers first reported a position in Treace Medical Concepts in Q1 2022 and held it in 5 quarters.
Gabelli & Co Investment Advisers's Treace Medical Concepts position peaked at $252K in Q1 2023.
137 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2023, filed 10 Aug 2023.